Patent 9611479 was granted and assigned to Osaka University on April, 2017 by the United States Patent and Trademark Office.
Disclosed are bridged nucleosides and nucleotides. The nucleosides of the present invention have a 2′,4′-bridged structure and are represented by formula I below: